ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
基本信息
- 批准号:8508208
- 负责人:
- 金额:$ 30.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-10 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAllelesAnaphaseAneuploidyAntibodiesAutomobile DrivingBindingBiochemicalBrainBreastCatenated DNACell Cycle ProgressionCell NucleusCellsChIP-seqChimeric ProteinsChromatinChromatin StructureCommon NeoplasmComplexDNADataDatabasesDependenceDevelopmentDropsEventFailureFrequenciesFunctional disorderFundingGene FamilyGene TargetingGenesGenomeGrantGrowthHumanImpairmentIn VitroIndividualKidneyKnowledgeLaboratoriesLeadLightLungMalignant - descriptorMalignant NeoplasmsMapsMitosisMitoticMolecularMolecular ProbesMutateMutationOncogenicOvaryPhenotypePolycombProteinsRoleSMARCA2 geneSMARCB1 geneSMARCC1 geneSiteSolutionsTailTertiary Protein StructureTimeTissuesTopoisomeraseTopoisomerase IITumor Suppressor ProteinsWorkX Chromosomecell typechromatin remodelingdefined contributionexome sequencinggain of functiongenome-wideinhibitor/antagonistinsightintegrase interactor 1loss of function mutationmedulloblastomamembermutantneoplastic cellnovelnovel therapeuticsoverexpressionpluripotencypreventrestraintsarcomasmall moleculesynovial sarcomatumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Recent screens for driving mutations in human malignancy have repeatedly identified subunits of mammalian SWI/SNF-like BAF complexes as tumor suppressors. Biochemical studies indicate that the identified subunits: BAF250a, Brg (BAF190), BAF155, BAF60b, BAF53a, and BAF47 (hSNF5) are dedicated to these complexes and not found as individual proteins or as parts of other complexes. In addition, we have recently found that SS18 (mutated in Synovial Sarcoma), Bcl7 and Bcl11 appear to be dedicated, stable subunits of BAF complexes. These studies suggest that SWI/SNF-like BAF complexes might be one of the most commonly mutated chromatin regulators in human cancer. BAF complexes regulate chromatin structure and are composed of about 14 subunits that are combinatorially assembled from the products of gene families encoding the subunits. The mechanisms underlying their frequent mutation in cancer are unclear. We have found that conditional deletion or depletion of the oncogenic subunits leads to stalling in mitosis and anaphase bridge formation, strongly implicating a failure to decatenate DNA during M phase. Importantly, Topoisomerase IIa (Topo IIa), which resolves catenated DNA at M phase associates with BAF complexes and Brg is essential for chromatin binding by Topo IIa. Furthermore, purified BAF complexes are required for optimal decatenation by purified Topo IIa in vitro. These observations suggest that a failure of decatenation by Topo IIa contributes to the genesis of human cancers, which is the central hypothesis of this application. This hypothesis is supported by the high frequency of concurrent mutations in other genes or aneuploidy in tumors bearing apparent initiating mutations in BAF subunits. To study these oncogenic BAF mutations, the SS18 translocation to SSX is particularly useful since it produces a sterotypic in-frame fusion of the SS18 BAF subunit to a member of the SSX gene family located on the X chromosome. This precise translocation attaches 78aa of SSX to SS18 and is almost certainly the driving event in synovial sarcoma (SS), which account for about 8% of sarcomas. Remarkably, the translocation of one allele leads to partial dissolution of BAF complexes. We will begin our studies by determining whether the SS18-SSX fusion causes a loss or gain of function for BAF complexes. We will define the consequences of this translocation for BAF complex binding over the genome to determine if target genes are lost or gained. We will then determine why the wildtype SS18 allele is repressed and leads to the formation of little protein compared to the translocated allele. We will examine the potentially oncogenic role of Topo IIa's dependence upon BAF complexes. Finally, we will attempt to understand how activating mutations in a- catenin and PI3K apparently cooperate with loss-of-function mutations in BAF subunits to lead to cancer. At the conclusion of our work we expect to have gained insight into the mechanism of transformation by mutations of the subunits of BAF complexes, which are emerging as major contributors to human cancer.
描述(由申请人提供):最近对人类恶性肿瘤中驱动突变的筛选已经反复鉴定出哺乳动物SWI/SNF样BAF复合物的亚基作为肿瘤抑制因子。生物化学研究表明,所鉴定的亚基:BAF 250 a、Brg(BAF 190)、BAF 155、BAF 60 b、BAF 53 a和BAF 47(hSNF 5)专用于这些复合物,而不是作为单独的蛋白质或作为其他复合物的一部分被发现。此外,我们最近发现,SS 18(滑膜肉瘤突变),Bcl 7和Bcl 11似乎是专用的,稳定的BAF复合物亚基。这些研究表明,SWI/SNF样BAF复合物可能是人类癌症中最常见的突变染色质调节因子之一。BAF复合物调节染色质结构,由约14个亚基组成,这些亚基由编码亚基的基因家族的产物组合组装而成。其在癌症中频繁突变的机制尚不清楚。我们已经发现,致癌亚基的条件性缺失或耗竭导致有丝分裂停滞和后期桥形成,强烈暗示在M期DNA解链失败。重要的是,拓扑异构酶IIa(Topo IIa),其在M期分解链式DNA,与BAF复合物缔合,并且Brg对于Topo IIa结合染色质是必需的。此外,纯化的BAF复合物需要通过纯化的Topo IIa在体外进行最佳脱链。这些观察结果表明,Topo IIa的去连环化失败有助于人类癌症的发生,这是本申请的中心假设。这一假设得到了其他基因中的高频率并发突变或BAF亚基中携带明显起始突变的肿瘤中的非整倍体的支持。为了研究这些致癌BAF突变,SS 18易位到SSX是特别有用的,因为它产生SS 18 BAF亚基与位于X染色体上的SSX基因家族成员的立体型框内融合。这种精确的易位将SSX的78 aa连接到SS 18上,并且几乎可以肯定是滑膜肉瘤(SS)中的驱动事件,其占肉瘤的约8%。值得注意的是,一个等位基因的易位导致BAF复合物的部分溶解。我们将开始我们的研究,确定是否SS 18-SSX融合导致BAF复合物的功能的损失或增益。我们将定义BAF复合物结合基因组的这种易位的后果,以确定靶基因是丢失还是获得。然后,我们将确定为什么野生型SS 18等位基因被抑制,并导致形成很少的蛋白质相比,易位的等位基因。我们将研究潜在的致癌作用拓扑IIa的依赖BAF复合物。最后,我们将试图了解α-连环蛋白和PI 3 K中的激活突变如何与BAF亚基中的功能丧失突变协同作用导致癌症。在我们的工作结束时,我们期望已经深入了解BAF复合物亚基突变的转化机制,BAF复合物亚基突变正在成为人类癌症的主要贡献者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gerald R. Crabtree其他文献
Signaling through calcium, calcineurin, and NF-AT in lymphocyte activation and development.
在淋巴细胞激活和发育过程中通过钙、钙调神经磷酸酶和 NF-AT 发出信号。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
K. Stankunas;Isabella A. Graef;J. Neilson;S.;Gerald R. Crabtree - 通讯作者:
Gerald R. Crabtree
lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin
白细胞介素 2 介导的 p27Kipl 细胞周期蛋白依赖性激酶抑制剂的消除被雷帕霉素阻止
- DOI:
10.1038/372570a0 - 发表时间:
1994-12-08 - 期刊:
- 影响因子:48.500
- 作者:
Jamison Nourse;Eduardo Firpo;W. Michael Flanagan;Steve Coats;Kornelia Polyak;Mong-Hong Lee;Joan Massague;Gerald R. Crabtree;James M. Roberts - 通讯作者:
James M. Roberts
Signaling via GSK-3 is required during midline skeletogenesis
- DOI:
10.1016/j.ydbio.2006.04.337 - 发表时间:
2006-07-01 - 期刊:
- 影响因子:
- 作者:
Karen J. Liu;Joseph R. Arron;Kryn Stankunas;Gerald R. Crabtree - 通讯作者:
Gerald R. Crabtree
Regulation of the regulators
监管者的监管
- DOI:
10.1038/35040690 - 发表时间:
2000-11-02 - 期刊:
- 影响因子:48.500
- 作者:
Scott Stewart;Gerald R. Crabtree - 通讯作者:
Gerald R. Crabtree
Regulation of the regulators
监管者的监管
- DOI:
10.1038/35040690 - 发表时间:
2000-11-02 - 期刊:
- 影响因子:48.500
- 作者:
Scott Stewart;Gerald R. Crabtree - 通讯作者:
Gerald R. Crabtree
Gerald R. Crabtree的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gerald R. Crabtree', 18)}}的其他基金
HIJACKING CANCER DRIVERS TO ACTIVATE PROAPOPTOTIC GENES IN DLBCL
劫持癌症驱动者激活 DLBCL 中的促凋亡基因
- 批准号:
10564195 - 财政年份:2022
- 资助金额:
$ 30.74万 - 项目类别:
Small molecule regulation of endogenous transcription factors for circuit-specific neuromodulation
内源转录因子的小分子调节用于电路特异性神经调节
- 批准号:
10260250 - 财政年份:2021
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
9900916 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
8371602 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
9903224 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
10586587 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
9054819 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
ATP-Dependent Chromatin Remodeling in Human Malignancy
人类恶性肿瘤中 ATP 依赖性染色质重塑
- 批准号:
8892817 - 财政年份:2012
- 资助金额:
$ 30.74万 - 项目类别:
Screen for Small Molecule Inhibitors of ATP Dependent Chromatin Remodeling
筛选 ATP 依赖性染色质重塑的小分子抑制剂
- 批准号:
8139341 - 财政年份:2011
- 资助金额:
$ 30.74万 - 项目类别:
Screen for Small Molecule Inhibitors of ATP Dependent Chromatin Remodeling
筛选 ATP 依赖性染色质重塑的小分子抑制剂
- 批准号:
8236903 - 财政年份:2011
- 资助金额:
$ 30.74万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 30.74万 - 项目类别:
Standard Grant